News
19h
Vietnam Investment Review on MSNIvonescimab Approved in China as First-Line Treatment for PD-L1+ Lung CancerIvonescimab is the first therapy to achieve statistically significant positive results in a Phase III trial compared with ...
CANCER remains a critical health challenge in Malaysia. This rising trend highlights the urgent need for effective ...
A Tain engineer who was diagnosed with bowel cancer at the age of 41 is saddling up to back an awareness month.
Medtronic plc , a global leader in healthcare technology, today announced positive clinical outcomes from two studies in atrial fibrillation (AFib) patients treated with the Afferatm family of ...
Pfizer Inc. today announced results from the pivotal Phase 3 CREST trial of sasanlimab, an investigational anti-PD-1 monoclonal antibody (mAb), in combination with standard of care (SOC) Bacillus ...
12h
Essex Live on MSN'My brother was in the prime of his life - 10 months later he was on his deathbed'I remember my dad saying: “if my brother had half my confidence, and I had half his skill, we’d both be much better ...
Summit Therapeutics' shares dropped 36% after ivonescimab data showed no significant survival benefit. Click to read if SMMT ...
Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.
Idiopathic pulmonary fibrosis (IPF) occurs when scar tissue builds up in the lungs, causing the walls to stiffen and making ...
People with diseases caused by rare mutations have fewer options and poorer prospects than other patients despite rapid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results